If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

The Role of ImmuKnow® in the Management of Immunosuppressants in the Renal Transplant Patient

October 03, 2011

More Renal Transplant Clinical Trials

I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Everolimus Rescue Immunosuppression in the Treatment of Chronic Allograft Dysfunction in Renal Transplant Recipients
Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant
Thymoglobulin Induction in Kidney Transplant Recipients (TIKT)
Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance

More in Renal Transplant Clinical Trials:

Analysis of Foxp3 and Vimentin Expression in Renal Transplant Recipient (TUFEV)

RENAL & UROLOGY NEWS SITEMAP

Nephrology

Acute Renal Failure
Anemia
Chronic Kidney Disease
Contrast Nephropathy
Cardiovascular Disease
Diabetes
Diabetic Nephropathy
Focal Segmental Glomerulosclerosis
Hemodialysis
Hypertension
Kidney Cancer
Kidney Stones
Lupus Nephritis
Peritoneal Dialysis
Secondary Hyperparathyroidism
Transplantation

Jobs

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions

The Role of ImmuKnow® in the Management of Immunosuppressants in the Renal Transplant Patient

More Renal Transplant Clinical Trials

RENAL & UROLOGY NEWS SITEMAP

News

Departments

More

Nephrology

Jobs

Urology

Archives

Other Haymarket Medical Websites

International